Literature DB >> 35654833

Sedation for less invasive surfactant administration in preterm infants: a systematic review and meta-analysis.

Laura Moschino1, Viraraghavan Vadakkencherry Ramaswamy2, Irwin Karl Marcel Reiss3, Eugenio Baraldi1, Charles Christoph Roehr4,5,6, Sinno Henricus Paulus Simons3.   

Abstract

BACKGROUND: Sedation to preterm neonates receiving less invasive surfactant administration (LISA) for respiratory distress syndrome is controversial.
METHODS: Systematic review and meta-analysis of randomized controlled trials (RCTs) and observational studies (OS) to evaluate the effect of sedative drugs for LISA on respiratory outcomes and adverse effects.
RESULTS: One RCT (78 neonates) and two OS (519 neonates) were analyzed in pairwise meta-analysis and 30 studies (2164 neonates) in proportion-based meta-analysis. Sedative drugs might not affect the duration of the procedure [RCT: mean difference (MD) (95% CI); -11 (-90; 67) s; OS: MD 95% CI: -60 (-178; 58) s; low certainty of evidence (CoE)]. Evidence for success at the first attempt and rescue intubation was uncertain (very low CoE). The risk of nasal intermittent positive pressure ventilation [RCT: 1.97 (1.38-2.81); OS: RR, 95% CI: 2.96 (1.46; 6.00), low CoE], desaturation [RCT: RR, 95% CI: 1.30 (1.03; 1.65), low CoE], and apnea [OS: RR, 95% CI: 3.13 (1.35; 7.24), very low CoE] might be increased with sedation. Bradycardia, hypotension, and mechanical ventilation were comparable between groups (low CoE).
CONCLUSIONS: Use of sedative drugs for LISA temporarily affects the newborn's breathing. Further trials are warranted to explore the use of sedation for LISA. IMPACT: The effect of sedative drugs (analgesics, sedatives, anesthetics) compared to the effect of no-sedation for LISA in preterm infants with RDS is underexplored. This systematic review and meta-analysis assesses the impact of sedative drugs compared to no-sedation for LISA on short-term pulmonary outcomes and potential adverse events. Sedative drugs for LISA temporarily affect the newborn's breathing (desaturation, apnea) and increase the need for nasal intermittent positive pressure ventilation. For most outcomes, certainty of evidence is low/very low.
© 2022. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.

Entities:  

Year:  2022        PMID: 35654833     DOI: 10.1038/s41390-022-02121-9

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  57 in total

Review 1.  Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis.

Authors:  Jose C Aldana-Aguirre; Merlin Pinto; Robin M Featherstone; Manoj Kumar
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2016-11-15       Impact factor: 5.747

Review 2.  Minimally invasive surfactant administration in preterm infants: a meta-narrative review.

Authors:  Kiran More; Pankaj Sakhuja; Prakesh S Shah
Journal:  JAMA Pediatr       Date:  2014-10       Impact factor: 16.193

3.  European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update.

Authors:  David G Sweet; Virgilio Carnielli; Gorm Greisen; Mikko Hallman; Eren Ozek; Arjan Te Pas; Richard Plavka; Charles C Roehr; Ola D Saugstad; Umberto Simeoni; Christian P Speer; Maximo Vento; Gerhard H A Visser; Henry L Halliday
Journal:  Neonatology       Date:  2019-04-11       Impact factor: 4.035

4.  Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial.

Authors:  Wolfgang Göpel; Angela Kribs; Andreas Ziegler; Reinhard Laux; Thomas Hoehn; Christian Wieg; Jens Siegel; Stefan Avenarius; Axel von der Wense; Matthias Vochem; Peter Groneck; Ursula Weller; Jens Möller; Christoph Härtel; Sebastian Haller; Bernhard Roth; Egbert Herting
Journal:  Lancet       Date:  2011-09-29       Impact factor: 79.321

5.  Nonintubated Surfactant Application vs Conventional Therapy in Extremely Preterm Infants: A Randomized Clinical Trial.

Authors:  Angela Kribs; Claudia Roll; Wolfgang Göpel; Christian Wieg; Peter Groneck; Reinhard Laux; Norbert Teig; Thomas Hoehn; Wolfgang Böhm; Lars Welzing; Matthias Vochem; Marc Hoppenz; Christoph Bührer; Katrin Mehler; Hartmut Stützer; Jeremy Franklin; Andreas Stöhr; Egbert Herting; Bernhard Roth
Journal:  JAMA Pediatr       Date:  2015-08       Impact factor: 16.193

Review 6.  Surfactant instillation in spontaneously breathing preterm infants: a systematic review and meta-analysis.

Authors:  Vincent Rigo; Caroline Lefebvre; Isabelle Broux
Journal:  Eur J Pediatr       Date:  2016-09-27       Impact factor: 3.183

7.  Less invasive surfactant administration in preterm infants with respiratory distress syndrome-an updated meta-analysis.

Authors:  Zhao-Lan Cao; Jing-Jing Pan; Xian Shen; Xiao-Yu Zhou; Rui Cheng; Xiao-Guang Zhou; Yang Yang
Journal:  J Chin Med Assoc       Date:  2020-02       Impact factor: 2.743

8.  Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome.

Authors:  Mohamed E Abdel-Latif; Peter G Davis; Kevin I Wheeler; Antonio G De Paoli; Peter A Dargaville
Journal:  Cochrane Database Syst Rev       Date:  2021-05-10

9.  Less Invasive Surfactant Administration Reduces the Need for Mechanical Ventilation in Preterm Infants: A Meta-Analysis.

Authors:  Christine S M Lau; Ronald S Chamberlain; Shyan Sun
Journal:  Glob Pediatr Health       Date:  2017-03-24

Review 10.  Surfactant replacement therapy: from biological basis to current clinical practice.

Authors:  Roland Hentschel; Kajsa Bohlin; Anton van Kaam; Hans Fuchs; Olivier Danhaive
Journal:  Pediatr Res       Date:  2020-01-11       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.